Dr. Harry Bear on Translating Pathological Complete Response to OS Benefits

Harry Bear, MD, PhD

Bear discusses studies adding treatments to chemotherapy in order to increase the pathological complete response (pCR) rate and the difficulties of translating those benefits into better overall survival (OS) rates for patients with breast cancer.

Harry Bear, MD, PhD, chair, Surgical Oncology, Virginia Commonwealth University Health, discusses studies adding treatments to chemotherapy in order to increase the pathological complete response (pCR) rate and the difficulties of translating those benefits into better overall survival (OS) rates for patients with breast cancer. Bear says in order to impact OS, the treatment a patient is given must greatly impact their pCR.